New therapies in the clinic for bipolar disorder hope to meet unmet needs of efficacy and minimal side effects.

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.

Artificial intelligence (AI) may be transforming drug discovery, but one of the industry’s biggest problems remains unchanged: much of the biology used to develop new medicines still does not fully ...

Over the past year, a growing number of companies have relaunched under fresh brands, often accompanied by promises of a new chapter, renewed focus, or a transformed business strategy. On the surface, ...

For a long time, neurological drug development has largely focused on the cells that ultimately die or malfunction. Alzheimer’s researchers chased amyloid and tau. Parkinson’s drug development ...

A shift in the European pharma sector’s center of gravity might be underway as Spain continues to build on its reputation for innovative biotechnology and life science. Now ranked third in scientific ...

Atopic dermatitis is a chronic, relapsing inflammatory skin disorder characterized by eczematous lesions and intense itchiness, which can substantially impair an individual’s quality of life. Over the ...

U.K.-based biotech Allergy Therapeutics is focused on diagnosing and developing treatments for allergic disorders, including aluminium-free immunotherapies that have the potential to cure disease. The ...

A significant trend in the cell and gene therapy space is the swing towards in vivo therapies. In vivo, simply put, means inside the body. Cell and gene therapies are often developed ex vivo – outside ...